1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Rising Prevalence of Antibiotic Resistance
3.2.1.2. Aging Population
3.2.1.3. Increase in Invasive Medical Procedures
3.2.1.4. Growing Awareness of ABSSSI
3.2.2. Restraints
3.2.2.1. High Cost of Treatment
3.2.2.2. Limited Availability of Effective Antibiotics
3.2.3. Opportunities
3.2.3.1. Technological Advancements in Diagnostics and Treatment
3.2.3.2. Focus on Emerging Markets
3.2.4. Challenges
3.2.4.1. Improper Antibiotic Use and Self-Medication
3.2.4.2. Lack of Awareness and Hygiene Practices
3.3. Technological Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter's Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market: Marketing Strategies
5. Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market: Geographical Analysis
5.1. Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market, Geographical Analysis, 2023
5.2. Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market, Market Attractiveness Analysis, 2024-2030
6. Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market Overview
6.1. Market Size & Forecast, 2019-2030
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Type of Infection
6.2.1.1. Hospital-acquired ABSSI
6.2.1.2. Community-acquired ABSSI
6.2.2. By Route of Administration
6.2.2.1. Oral
6.2.2.2. ParentaL
6.2.2.3. Topical
6.2.3. By Distribution Channel
6.2.3.1. Hospital Pharmacies
6.2.3.2. Retail Pharmacies
6.2.3.3. Online Pharmacies
6.2.4. By Region
6.2.4.1. North America
6.2.4.2. Europe
6.2.4.3. Asia Pacific (APAC)
6.2.4.4. Latin America (LATAM)
6.2.4.5. Middle East and Africa (MEA)
7. North America Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market
7.1. Market Size & Forecast, 2019-2030
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Type of Infection
7.2.2. By Route of Administration
7.2.3. By Distribution Channel
7.2.4. By Country
7.2.4.1. United States
7.2.4.1.1. By Type of Infection
7.2.4.1.2. By Route of Administration
7.2.4.1.3. By Distribution Channel
7.2.4.2. Canada
7.2.4.2.1. By Type of Infection
7.2.4.2.2. By Route of Administration
7.2.4.2.3. By Distribution Channel
8. Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market
8.1. Market Size & Forecast, 2019-2030
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Type of Infection
8.2.2. By Route of Administration
8.2.3. By Distribution Channel
8.2.4. By Country
8.2.4.1. Germany
8.2.4.1.1. By Type of Infection
8.2.4.1.2. By Route of Administration
8.2.4.1.3. By Distribution Channel
8.2.4.2. United Kingdom
8.2.4.2.1. By Type of Infection
8.2.4.2.2. By Route of Administration
8.2.4.2.3. By Distribution Channel
8.2.4.3. Italy
8.2.4.3.1. By Type of Infection
8.2.4.3.2. By Route of Administration
8.2.4.3.3. By Distribution Channel
8.2.4.4. France
8.2.4.4.1. By Type of Infection
8.2.4.4.2. By Route of Administration
8.2.4.4.3. By Distribution Channel
8.2.4.5. Spain
8.2.4.5.1. By Type of Infection
8.2.4.5.2. By Route of Administration
8.2.4.5.3. By Distribution Channel
8.2.4.6. Belgium
8.2.4.6.1. By Type of Infection
8.2.4.6.2. By Route of Administration
8.2.4.6.3. By Distribution Channel
8.2.4.7. Russia
8.2.4.7.1. By Type of Infection
8.2.4.7.2. By Route of Administration
8.2.4.7.3. By Distribution Channel
8.2.4.8. The Netherlands
8.2.4.8.1. By Type of Infection
8.2.4.8.2. By Route of Administration
8.2.4.8.3. By Distribution Channel
8.2.4.9. Rest of Europe
8.2.4.9.1. By Type of Infection
8.2.4.9.2. By Route of Administration
8.2.4.9.3. By Distribution Channel
9. Asia Pacific Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market
9.1. Market Size & Forecast, 2019-2030
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Type of Infection
9.2.2. By Route of Administration
9.2.3. By Distribution Channel
9.2.4. By Country
9.2.4.1. China
9.2.4.1.1. By Type of Infection
9.2.4.1.2. By Route of Administration
9.2.4.1.3. By Distribution Channel
9.2.4.2. India
9.2.4.2.1. By Type of Infection
9.2.4.2.2. By Route of Administration
9.2.4.2.3. By Distribution Channel
9.2.4.3. Japan
9.2.4.3.1. By Type of Infection
9.2.4.3.2. By Route of Administration
9.2.4.3.3. By Distribution Channel
9.2.4.4. South Korea
9.2.4.4.1. By Type of Infection
9.2.4.4.2. By Route of Administration
9.2.4.4.3. By Distribution Channel
9.2.4.5. Australia & New Zealand
9.2.4.5.1. By Type of Infection
9.2.4.5.2. By Route of Administration
9.2.4.5.3. By Distribution Channel
9.2.4.6. Indonesia
9.2.4.6.1. By Type of Infection
9.2.4.6.2. By Route of Administration
9.2.4.6.3. By Distribution Channel
9.2.4.7. Malaysia
9.2.4.7.1. By Type of Infection
9.2.4.7.2. By Route of Administration
9.2.4.7.3. By Distribution Channel
9.2.4.8. Singapore
9.2.4.8.1. By Type of Infection
9.2.4.8.2. By Route of Administration
9.2.4.8.3. By Distribution Channel
9.2.4.9. Vietnam
9.2.4.9.1. By Type of Infection
9.2.4.9.2. By Route of Administration
9.2.4.9.3. By Distribution Channel
9.2.4.10. Rest of APAC
9.2.4.10.1. By Type of Infection
9.2.4.10.2. By Route of Administration
9.2.4.10.3. By Distribution Channel
10. Latin America Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market
10.1. Market Size & Forecast, 2019-2030
10.1.1. By Value (USD Million)
10.2. Market Share & Forecast
10.2.1. By Type of Infection
10.2.2. By Route of Administration
10.2.3. By Distribution Channel
10.2.4. By Country
10.2.4.1. Brazil
10.2.4.1.1. By Type of Infection
10.2.4.1.2. By Route of Administration
10.2.4.1.3. By Distribution Channel
10.2.4.2. Mexico
10.2.4.2.1. By Type of Infection
10.2.4.2.2. By Route of Administration
10.2.4.2.3. By Distribution Channel
10.2.4.3. Argentina
10.2.4.3.1. By Type of Infection
10.2.4.3.2. By Route of Administration
10.2.4.3.3. By Distribution Channel
10.2.4.4. Peru
10.2.4.4.1. By Type of Infection
10.2.4.4.2. By Route of Administration
10.2.4.4.3. By Distribution Channel
10.2.4.5. Rest of LATAM
10.2.4.5.1. By Type of Infection
10.2.4.5.2. By Route of Administration
10.2.4.5.3. By Distribution Channel
11. Middle East & Africa Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market
11.1. Market Size & Forecast, 2019-2030
11.1.1. By Value (USD Million)
11.2. Market Share & Forecast
11.2.1. By Type of Infection
11.2.2. By Route of Administration
11.2.3. By Distribution Channel
11.2.4. By Country
11.2.4.1. Saudi Arabia
11.2.4.1.1. By Type of Infection
11.2.4.1.2. By Route of Administration
11.2.4.1.3. By Distribution Channel
11.2.4.2. UAE
11.2.4.2.1. By Type of Infection
11.2.4.2.2. By Route of Administration
11.2.4.2.3. By Distribution Channel
11.2.4.3. Qatar
11.2.4.3.1. By Type of Infection
11.2.4.3.2. By Route of Administration
11.2.4.3.3. By Distribution Channel
11.2.4.4. Kuwait
11.2.4.4.1. By Type of Infection
11.2.4.4.2. By Route of Administration
11.2.4.4.3. By Distribution Channel
11.2.4.5. South Africa
11.2.4.5.1. By Type of Infection
11.2.4.5.2. By Route of Administration
11.2.4.5.3. By Distribution Channel
11.2.4.6. Nigeria
11.2.4.6.1. By Type of Infection
11.2.4.6.2. By Route of Administration
11.2.4.6.3. By Distribution Channel
11.2.4.7. Algeria
11.2.4.7.1. By Type of Infection
11.2.4.7.2. By Route of Administration
11.2.4.7.3. By Distribution Channel
11.2.4.8. Rest of MEA
11.2.4.8.1. By Type of Infection
11.2.4.8.2. By Route of Administration
11.2.4.8.3. By Distribution Channel
12. Competitive Landscape
12.1. List of Key Players and Their Offerings
12.2. Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Company Market Share Analysis, 2023
12.3. Competitive Benchmarking, By Operating Parameters
12.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
13. Impact of Escalating Geopolitical Tensions on Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market
14. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
14.1. Pfizer
14.2. Merck & Co.
14.3. AbbVie
14.4. F. Hoffmann-La Roche Ltd
14.5. GlaxoSmithKline
14.6. Johnson & Johnson
14.7. Eli Lilly and Company
14.8. Novartis AG
14.9. Sanofi S.A.
14.10. AstraZeneca PLC
14.11. Teva Pharmaceutical Industries Ltd
14.12. Mylan N.V.
14.13. Other Prominent Players
15. Key Strategic Recommendations
16. Research Methodology
16.1. Qualitative Research
16.1.1. Primary & Secondary Research
16.2. Quantitative Research
16.3. Market Breakdown & Data Triangulation
16.3.1. Secondary Research
16.3.2. Primary Research
16.4. Breakdown of Primary Research Respondents, By Region
16.5. Assumptions & Limitations
*Financial information of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable